Vincerx PharmaVINC
13F holders, Q4 2024 (December 31)1holders
$0.26avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Vincerx Pharma Inc. (VINC) in their 13F filings. The largest holder was SBI Securities Co., Ltd. ($263).
- Company
- Vincerx Pharma Inc.
- CUSIP
- 92731L304
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024
No earlier quarter to compare with.
Ownership 1 holders
| SBI Securities Co., Ltd. | 0.00% | — | 1,000 | $263 |
"% of holder's portfolio" is VINC's weight in each manager's 13F, not the share of Vincerx Pharma Inc. the manager owns.